FULL SUPPLEMENT: Why Care About Skin Care When Managing Acne?

December 2022 | Volume 21 | Issue 12 | SF3509931 | Copyright © December 2022


Published online November 30, 2022

Abstract
A specific skincare regimen incorporating both a designated cleanser and moisturizer is reviewed with study results reported from 44 adult patients with AV. The designated cleanser is Cetaphil Gentle Clear Clarifying Acne Cream Cleanser (CGCAC; Galderma) and the designated moisturizer is Cetaphil Gentle Clear Mattifying Acne Moisturizer (CGCAM; Galderma). A multicenter, in-use, 12-week study was completed to assess the efficacy, tolerability, and cosmetic acceptability of the above products used in a stepwise approach twice daily in adult patients with mild facial AV.
In this supplement:

Bridging the Gap: Optimizing Skin Care in Acne Treatment
To optimize the treatment of dermatologic diseases, one must recognize the interplay between maintaining the function of the skin barrier and utilizing topical medications which often disrupt the former.

Read the article here.

Optimizing Skin Care in Acne Treatment – Evaluation of a Designated Cleanser and Moisturizer Regimen With Improvement in Clinical Outcomes
Acne vulgaris (AV) is one of the most common skin disorders encountered in outpatient dermatology practice worldwide, commonly affecting adolescents, but also pre-teens and postadolescent adults of any race, ethnicity, and skin color.

Read the article here.
Close Menu